0001851860 false 0001851860 2022-11-28 2022-11-28 0001851860 dei:FormerAddressMember 2022-11-28 2022-11-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 2, 2022 (November 28, 2022)

 

SMART FOR LIFE, INC.
(Exact name of registrant as specified in its charter)

 

Delaware   001-41290   81-5360128
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

990 S Rogers Circle, Suite 3, Boca Raton, FL   33487
(Address of principal executive offices)   (Zip Code)

 

(786) 749-1221
(Registrant’s telephone number, including area code)

 

990 Biscayne Blvd., Suite 503, Miami, FL 33132
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   SMFL   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

Lease Agreement

 

On November 28, 2022, Smart for Life, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with 990 S Rogers Circle, LLC (the “Landlord”) for a 7,877 square foot premises located in Boca Raton, Florida, which will serve as the Company’s new corporate headquarters. The term of the Lease commenced on December 1, 2022 and ends on December 31, 2029, with one option to extend the term for five years. The monthly rent is approximately $13,283 for the first year, with 3.5% annual increases to approximately $16,328 in the final year of the initial term. The Company is also responsible for its proportionate (5.69%) share of any increases to the Landlord’s taxes, insurance and common area maintenance costs after December 31, 2022. The Lease contains other customary representations and warranties, covenants and events of default for a commercial lease of this type.

 

Amendments to Promissory Notes

 

As previously disclosed, on July 29, 2022, the Company issued secured subordinated promissory notes in the aggregate principal amount of $1,300,000 (the “Ceautamed Notes”) in connection with its acquisition of Ceautamed Worldwide, LLC. The Ceautamed Notes bear interest at the rate of five percent (5%) per annum with all principal and accrued interest being due and payable in one lump sum ninety (90) days from the date of the Ceautamed Notes; provided that upon an event of default (as defined in the Ceautamed Notes), such interest rate shall increase to ten percent (10%).

 

On November 28, 2022, the Company entered into letter agreements with the holders of most of the Ceautamed Notes to amend the terms of the Ceautamed Notes (the “Ceautamed Amendments”). Pursuant to the Ceautamed Amendments, the parties agreed to extend the maturity date of the Ceautamed Notes to June 1, 2023 and agreed to a seven month payment schedule, with the first payment due December 1, 2022. The parties also agreed to increase the default interest rate from ten percent (10%) to fifteen percent (15%). The Company also agreed that if an event of default (as defined in the Ceautamed Notes) has occurred and is continuing, then the Company shall not create any senior indebtedness (as defined in the Ceautamed Notes) without the consent of the holders of a majority of the principal amount of the Ceautamed Notes. In exchange for the agreement of the holders of the Ceautamed Notes to enter into the Ceautamed Amendments, the Company agreed to pay certain amendment fees as more particularly described in the Ceautamed Amendments. The Company is in the process of negotiating a similar extension of one remining Ceautamed Note in the principal amount of $100,000.

 

As previously disclosed, on July 1, 2021, the Company issued a 6% secured subordinated promissory note in the principal amount of $3,000,000 to Sasson E. Moulavi (the “DSO Note”) in connection with its acquisition of Doctors Scientific Organica, LLC. The DSO Note accrues interest at 6% per annum with the outstanding principal and interest amortized on a straight-line basis and payable quarterly in accordance with the amortization schedule attached to the DSO Note, with all amounts due and payable on July 1, 2024.

 

On November 29, 2022, the Company entered into a letter agreement with Dr. Moulavi to amend the terms of the DSO Note (the “DSO Amendment”). Pursuant to the DSO Amendment, the parties agreed to amend and restate the DSO Note to amend the amortization schedule attached thereto, with the first payment deferred until February 15, 2023 and all amounts due and payable on August 15, 2024 (the “Amended and Restated Note”). In exchange for the agreement of Dr. Moulavi to enter into the DSO Amendment, the Company agreed to (i) issue to Dr. Moulavi 100,000 shares of its common stock under the Company’s 2022 Equity Incentive Plan and (ii) pay to Dr. Moulavi a fee of $50,000 in cash, which shall be paid upon completion of the Company’s anticipated debt financing expected to close by December 31, 2022.

 

The foregoing summary of the terms and conditions of the Lease, and the Ceautamed Amendments, the DSO Amendment and the Amended and Restated Note does not purport to be complete and is qualified in its entirety by reference to the full text of those documents attached as Exhibits hereto, which are incorporated herein by reference.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information set forth under Item 1.01 is incorporated by reference into this Item 2.03.

 

1

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On November 28, 2022, the Company received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the Nasdaq stockholders’ equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market, as set forth in Listing Rule 5550(b), given that the Company’s Form 10-Q for the period ended September 30, 2022 evidenced stockholders’ equity of only $2,051,279. The Company was previously under a grace period for the $1.00 bid price requirement, as set forth in Listing Rule 5550(a)(2), that was set to expire on November 29, 2022. Given the stockholders’ equity deficiency, Nasdaq determined to terminate the grace period one day early, pursuant to its discretionary authority, as set forth in Listing Rule 5101. Based on the foregoing, the Company intends to timely request a hearing before a Nasdaq Hearings Panel. The hearing request will stay any suspension or delisting action pending the conclusion of the hearings process. At the hearing, the Company intends to present its plan for regaining compliance with the bid price and stockholders’ equity requirements and to request a further extension so that it may complete the execution of its plan. Although the Company believes its plan will be sufficient to enable it to regain compliance, no assurance can be provided that Nasdaq will ultimately accept the Company’s plan or that the Company will ultimately regain compliance with all applicable requirements for continued listing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description of Exhibit
10.1   Lease Agreement, dated November 28, 2022, between 990 S Rogers Circle, LLC and Smart for Life, Inc.
10.2   Secured Subordinated Promissory Note issued by Smart for Life, Inc. to RMB Industries, Inc. on July 29, 2022 (incorporated by reference to Exhibit 10.9 to the Current Report on Form 8-K filed on August 4, 2022)
10.3   Letter Agreement, dated November 28, 2022, between Smart for Life, Inc. and RMB Industries, Inc.
10.4   Secured Subordinated Promissory Note issued by Smart for Life, Inc. to D&D Hayes, LLC on July 29, 2022 (incorporated by reference to Exhibit 10.10 to the Current Report on Form 8-K filed on August 4, 2022)
10.5   Letter Agreement, dated November 28, 2022, between Smart for Life, Inc. and D&D Hayes, LLC
10.6   Secured Subordinated Promissory Note issued by Smart for Life, Inc. to Stuart Benson on July 29, 2022 (incorporated by reference to Exhibit 10.12 to the Current Report on Form 8-K filed on August 4, 2022)
10.7   Letter Agreement, dated November 28, 2022, between Smart for Life, Inc. and Stuart Benson
10.8   6% Secured Subordinated Promissory Note issued by Smart for Life, Inc. to Sasson E. Moulavi on July 1, 2021 (incorporated by reference to Exhibit 10.20 to the Registration Statement on Form S-1 filed on December 16, 2021)
10.9   Letter Agreement, dated November 29, 2022, between Smart for Life, Inc. and Sasson E. Moulavi
10.10   Amended and Restated 6% Secured Subordinated Promissory Note issued by Smart for Life, Inc. to Sasson E. Moulavi on November 29, 2022
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 2, 2022 SMART FOR LIFE, INC.
   
  /s/ Darren C. Minton
  Name: Darren C. Minton
  Title: Chief Executive Officer

 

 

3

 

 

Exhibit 10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 10.3

 

Smart for Life, Inc.

990 Biscayne Blvd., Suite 503

Miami, FL 33132

 

November 28, 2022

 

RMB INDUSTRIES, INC.

1289 Clint Moore Road

Boca Raton, FL 33487

Attn: Ryan Benson

 

Mr. Benson:

 

Reference is made to that certain 5% Secured Subordinated Promissory Note in the principal amount of $125,000 issued by Smart for Life, Inc., a Delaware corporation (the “Company”) to RMB INDUSTRIES, INC. (the “Holder”) on July 29, 2022 (the “Note”). This Note is one of the Buyer Notes III (as defined in the Purchase Agreement) issued pursuant to that certain Securities Purchase Agreement, dated July 29, 2022 (as amended, the “Purchase Agreement”), by and among the Company, Ceautamed Worldwide, LLC and the Sellers (as defined in the Purchase Agreement). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Note.

 

The Company and the Holder previously agreed informally to extend the Maturity Date and now desire to formally extend the Maturity Date and amend the repayment terms and certain other terms of the Note. Accordingly, the Company and the Holder agree to amend the Note as follows:

 

a.Section 1 of the Note in hereby amended and restated in its entirety to read as follows:

 

“1. Principal Repayment. The outstanding Principal amount of this Note shall be payable in accordance with the payment schedule set forth on Exhibit A to this Note (the “Payment Schedule”), with all of the unpaid Principal and accrued, but unpaid Interest thereon being fully paid on June 1, 2023 (the “Maturity Date”). All payments of Interest and Principal shall be in lawful money of the United States of America. All payments of Interest and Principal in respect of the Buyer Notes III shall be made pro rata among the holders of the Buyer Notes III based on the amounts due and owing under each of the Buyer Notes III.”

 

b.Section 2(b) of the Note is hereby amended and restated in its entirety to read as follows:

 

“(b) Notwithstanding Section 2.2(a) above, during the continuance of any Event of Default (as defined herein), Interest shall accrue on the unpaid Principal at a rate per annum equal to the Interest Rate plus ten percent (10%).”

 

c.A new Section 7(l) is hereby added to the Note and shall read as follows:

 

“If an Event of Default has occurred and is continuing, the Company shall not create any Senior Indebtedness without the consent of holders of a majority in principal amount of the Buyer Notes III.”

 

The parties hereto agree that the amendments described above are effective retroactively to October 29, 2022. Except as amended as set forth above, the Note shall continue in full force and effect.

 

 

 

 

In consideration for the amendments described herein, the Company hereby agrees to amend the terms of that certain employment agreement, dated July 29, 2022, between Ryan Benson and the Company’s subsidiary Ceautamed Worldwide, LLC to increase Ryan Benson’s base salary to $250,000 commencing on December 1, 2022 (the “Amendment”). For clarification, the increase in salary contemplated by the Amendment is being paid to Ryan Benson, individually, instead of the Holder, at the Holder’s request and constitutes consideration for the amendments to the Note described herein.

 

The Company shall pay the attorneys’ fees of the Holder in connection with the amendments to the Note described herein.

 

By signing below, the parties hereto hereby consent and agree to amend the terms of the Note as set forth above, and the Holder agrees to the Amendment as consideration therefor, as set forth herein.

 

  Very truly yours,
   
  Smart for Life, Inc.
   
  By: /s/ Alfonso J. Cervantes, Jr.
  Name:  Alfonso J. Cervantes, Jr.
  Title: Executive Chairman

 

AGREED AND ACKNOWLEDGED:  
   
RMB INDUSTRIES, INC.  
   
By: /s/ Ryan Benson  
Name:   Ryan Benson  
Title: President  

 

2

 

 

EXHIBIT A

PAYMENT SCHEDULE

 

Payment Date  Principal
Paid
12/1/2022  $10,416.66
01/1/2023  $10,416.66
02/1/2023  $10,416.67
03/1/2023  $10,416.67
04/1/2023  $10,416.67
05/1/2023  $10,416.67
06/1/2023  $62,500.00

 

 

3

 

 

Exhibit 10.5

 

Smart for Life, Inc.

990 Biscayne Blvd., Suite 503

Miami, FL 33132

 

November 28, 2022

 

D&D Hayes, LLC

55900 Pebble Beach

La Quinta, CA 92253

Attn: Dr. Donald Hayes

 

Dr. Hayes:

 

Reference is made to that certain 5% Secured Subordinated Promissory Note in the principal amount of $300,000 issued by Smart for Life, Inc., a Delaware corporation (the “Company”) to D&D Hayes, LLC (the “Holder”) on July 29, 2022 (the “Note”). This Note is one of the Buyer Notes III (as defined in the Purchase Agreement) issued pursuant to that certain Securities Purchase Agreement, dated July 29, 2022 (as amended, the “Purchase Agreement”), by and among the Company, Ceautamed Worldwide, LLC and the Sellers (as defined in the Purchase Agreement). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Note.

 

The Company and the Holder previously agreed informally to extend the Maturity Date and now desire to formally extend the Maturity Date and amend the repayment terms and certain other terms of the Note. Accordingly, the Company and the Holder agree to amend the Note as follows:

 

a.Section 1 of the Note in hereby amended and restated in its entirety to read as follows:

 

“1. Principal Repayment. The outstanding Principal amount of this Note shall be payable in accordance with the payment schedule set forth on Exhibit A to this Note (the “Payment Schedule”), with all of the unpaid Principal and accrued, but unpaid Interest thereon being fully paid on June 1, 2023 (the “Maturity Date”). All payments of Interest and Principal shall be in lawful money of the United States of America. All payments of Interest and Principal in respect of the Buyer Notes III shall be made pro rata among the holders of the Buyer Notes III based on the amounts due and owing under each of the Buyer Notes III.”

 

b.Section 2(b) of the Note is hereby amended and restated in its entirety to read as follows:

 

“(b) Notwithstanding Section 2.2(a) above, during the continuance of any Event of Default (as defined herein), Interest shall accrue on the unpaid Principal at a rate per annum equal to the Interest Rate plus ten percent (10%).”

 

c.A new Section 7(l) is hereby added to the Note and shall read as follows:

 

“If an Event of Default has occurred and is continuing, the Company shall not create any Senior Indebtedness without the consent of holders of a majority in principal amount of the Buyer Notes III.”

 

The parties hereto agree that the amendments described above are effective retroactively to October 29, 2022. Except as amended as set forth above, the Note shall continue in full force and effect.

 

 

 

 

In consideration for the amendments described herein, the Company hereby agrees to pay to Dr. Donald Hayes, individually, instead of the Holder, as requested by the Holder, a fee of $12,000 (the “Amendment Fee”), which Amendment Fee shall be payable in six (6) equal monthly installments of $2,000 per month. The Amendment Fee shall be paid concurrently with payments made to Dr. Donald Hayes under that certain consulting agreement, dated July 29, 2022, between Dr. Donald Hayes and the Company, with the next monthly payment to be made on December 1, 2022. A failure to make any monthly installment of the Amendment Fee shall constitute an Event of Default under the Note. For the avoidance of doubt, the Amendment Fee is in addition to the payments due under the Note as set forth on Exhibit A to the Note.

 

The Company shall pay the attorneys’ fees of the Holder in connection with the amendments to the Note described herein.

 

By signing below, the parties hereto hereby consent and agree to amend the terms of the Note and the Holder agrees to the Amendment Fee as consideration therefor, as set forth herein.

 

  Very truly yours,
     
  Smart for Life, Inc.
     
  By: /s/ Alfonso J. Cervantes, Jr.
  Name:  Alfonso J. Cervantes, Jr.
  Title: Executive Chairman

 

AGREED AND ACKNOWLEDGED:  
     
D&D Hayes, LLC
     
By: /s/ Donald Hayes  
Name:   Donald Hayes  
Title: President  

 

2 

 

 

EXHIBIT A

PAYMENT SCHEDULE

 

Payment Date  Principal
Paid
12/1/2022  $20,000
01/1/2023  $20,000
02/1/2023  $20,000
03/1/2023  $20,000
04/1/2023  $20,000
05/1/2023  $20,000
06/1/2023  $180,000

 

 

3

 

 

Exhibit 10.7

 

Smart for Life, Inc.

990 Biscayne Blvd., Suite 503

Miami, FL 33132

 

November 28, 2022

 

Stuart Benson

6980 Queenferry Circle

Boca Raton, FL 33496

 

Mr. Benson:

 

Reference is made to that certain 5% Secured Subordinated Promissory Note in the principal amount of $775,000 issued by Smart for Life, Inc., a Delaware corporation (the “Company”) to you (the “Holder”) on July 29, 2022 (the “Note”). This Note is one of the Buyer Notes III (as defined in the Purchase Agreement) issued pursuant to that certain Securities Purchase Agreement, dated July 29, 2022 (as amended, the “Purchase Agreement”), by and among the Company, Ceautamed Worldwide, LLC and the Sellers (as defined in the Purchase Agreement). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Note.

 

The Company and the Holder previously agreed informally to extend the Maturity Date and now desire to formally extend the Maturity Date and amend the repayment terms and certain other terms of the Note. The Company and the Holder acknowledge that to date, the Company has paid the Holder an aggregate of $100,000 towards the Principal amount of the Note, resulting in a remaining Principal amount of $675,000. Accordingly, the Company and the Holder agree to amend the Note as follows:

 

a.Section 1 of the Note in hereby amended and restated in its entirety to read as follows:

 

“1. Principal Repayment. The outstanding Principal amount of this Note shall be payable in accordance with the payment schedule set forth on Exhibit A to this Note (the “Payment Schedule”), with all of the unpaid Principal and accrued, but unpaid Interest thereon being fully paid on June 1, 2023 (the “Maturity Date”). All payments of Interest and Principal shall be in lawful money of the United States of America. All payments of Interest and Principal in respect of the Buyer Notes III shall be made pro rata among the holders of the Buyer Notes III based on the amounts due and owing under each of the Buyer Notes III.”

 

b.Section 2(b) of the Note is hereby amended and restated in its entirety to read as follows:

 

“(b) Notwithstanding Section 2.2(a) above, during the continuance of any Event of Default (as defined herein), Interest shall accrue on the unpaid Principal at a rate per annum equal to the Interest Rate plus ten percent (10%).”

 

c.A new Section 7(l) is hereby added to the Note and shall read as follows:

 

“If an Event of Default has occurred and is continuing, the Company shall not create any Senior Indebtedness without the consent of holders of a majority in principal amount of the Buyer Notes III.”

 

The parties hereto agree that the amendments described above are effective retroactively to October 29, 2022. Except as amended as set forth above, the Note shall continue in full force and effect.

 

 

 

 

In consideration for the amendments described herein, the Company hereby agrees to pay to the Holder a fee of $108,000 (the “Amendment Fee”), which Amendment Fee shall be payable in six (6) equal monthly installments of $18,000 per month commencing on December 1, 2022 and ending on May 1, 2023. A failure to make any monthly installment of the Amendment Fee that is not cured within two (2) business days shall constitute an Event of Default under the Note. For the avoidance of doubt, the Amendment Fee is in addition to the payments due under the Note as set forth on Exhibit A to the Note.

 

The Company shall pay the attorneys’ fees of the Holder in connection with the amendments to the Note described herein.

 

By signing below, the parties hereto hereby consent and agree to amend the terms of the Note as set forth above, and the Company agrees to pay to the Holder, and the Holder agrees to accept, the Amendment Fee as consideration therefor, as set forth herein.

 

  Very truly yours,
   
  Smart for Life, Inc.
   
  By: /s/ Alfonso J. Cervantes, Jr.
  Name: Alfonso J. Cervantes, Jr.
  Title: Executive Chairman

 

AGREED AND ACKNOWLEDGED:  
   
/s/ Stuart Benson  
Stuart Benson  

 

2 

 

 

EXHIBIT A

PAYMENT SCHEDULE

 

Payment Date  Principal
Paid
12/1/2022  $69,583
01/1/2023  $69,583
02/1/2023  $69,583
03/1/2023  $69,583
04/1/2023  $69,583
05/1/2023  $69,583
06/1/2023  $257,502

 

 

3

 

Exhibit 10.9

 

Smart for Life, Inc.

990 Biscayne Blvd., Suite 503

Miami, FL 33132

 

November 29, 2022

 

Dr. Sasson E. Moulavi

1210 W 13th Street

Riviera Beach, FL 33404

 

Dr. Moulavi:

 

Reference is made to that certain Six Percent (6%) Secured Subordinated Promissory Note in the principal amount of Three Million Dollars ($3,000,000) issued by Smart for Life, Inc., a Delaware corporation (the “Company”) to you (the “Holder”) on July 1, 2021 (the “Original Note”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Note.

 

The Company and the Holder previously agreed informally to extend the first payment under the Amortization Schedule and now desire to formally extend the note payments by executing an Amended and Restated Note. The Amended and Restated Note, which includes a revised Amortization Schedule, is attached hereto as Exhibit “A”.

 

In consideration for the execution of the Amended and Restated Note, the Company hereby agrees to (i) issue to the Holder One Hundred Thousand (100,000) shares of its common stock under the Company’s 2022 Equity Incentive Plan and (ii) pay to the Holder a fee of $50,000 in cash, which shall be paid upon completion of the Company’s anticipated debt financing expected by December 31, 2022 (the “Amendment Fee”).

 

By signing below, the Holder hereby consents and agrees to execute the Amended and Restated Note and agrees to the Amendment Fee as consideration therefore, as set forth herein.

 

    Very truly yours,
     
    Smart for Life, Inc.
     
    By: /s/ A.J. Cervantes
    Name:  A.J. Cervantes
    Title: Executive Chairman
   
AGREED AND ACKNOWLEDGED:  
     
/s/ Dr. Sasson E. Moulavi    
Dr. Sasson E. Moulavi    

Exhibit 10.10

 

This Note constitutes an amendment and restatement of that certain Three Million Dollar ($3,000,000.00), Six Percent (6%) Secured Subordinated Promissory Note dated as of July 1, 2021 (as amended, restated, modified, or supplemented from time to time, the “Original Note”) issued by the Company in favor of the Holder, a copy of which is attached hereto as Exhibit “B”. All obligations under the Original Note are hereby renewed and continued, and hereafter will be governed by this Note. This Note shall be secured to the same extent and with the same priority as the Original Note. The execution and delivery of this Note shall not constitute a novation of any indebtedness or other obligations owing to the Holder under the Original Note. Nothing herein shall create or imply the existence of any commitment or obligation by the Holder to make any additional financial accommodation available to the Company hereunder. Documentary Stamps in connection with Original Note in the amount of Two Thousand Four Hundred Fifty Dollars ($2,450.00) have previously been paid to the Florida Department of Revenue.

 

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL, IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.

 

Smart for Life, Inc.

 

AMENDED AND RESTATED SIX PERCENT (6%) SECURED SUBORDINATED PROMISSORY NOTE

 

$3,000,000 November 29, 2022

 

For value received, Smart for Life, Inc. (formerly Bonne Santé Group, Inc.), a Delaware corporation (the “Company”), promises to pay to Dr. Sasson E. Moulavi, an individual (the “Holder”), the principal sum of Three Million Dollars ($3,000,000.00) (the “Principal”) together with accrued and unpaid Interest thereon, each due and payable on the date and in the manner set forth below.

 

This secured subordinated promissory Note (the “Note”) is issued pursuant to the terms of that certain Securities Purchase Agreement, dated February 11, 2020, as amended by the First Amendment to the Securities Purchase Agreement, dated July 13, 2020, and the Second Amendment to Securities Purchase Agreement, dated June 4, 2021, and the Third Amendment to the Securities Purchase Agreement dated June 30, 2021 (as so amended, “Purchase Agreement”), among the Company, Doctors Scientific Organica LL.C., Oyster Management Services Ltd., Lawee Enterprises L.L.C., U.S. Medical Care Holdings, L.L.C., and the Holder. Capitalized terms used herein without definition shall have the meanings given to such terms in the Purchase Agreement.

 

 

 

 

The following is a statement of the rights of the Holder of this Note and the terms and conditions to which this Note is subject and to which the Holder, by acceptance of this Note, agrees:

 

1. Principal Repayment. The outstanding principal amount of this Note and all accrued Interest shall be amortized in accordance with the amortization schedule set forth on Exhibit “A” to this Note (the “Amortization Schedule”), with all of the unpaid Principal and accrued but unpaid Interest thereon (including Interest due prior to February 2023) being fully paid on August 15, 2024 (the “Maturity Date”). All payments of Interest and Principal shall be in lawful money of the United States of America.

 

2. Interest. Interest (the “Interest”) shall accrue on the unpaid Principal from the date hereof until such Principal is repaid in full at the rate of six percent (6%) per annum. Interest shall be paid in accordance with the Amortization Schedule, with all unpaid Interest being paid on the Maturity Date or the date of the redemption of this Note. All computations of the Interest rate hereunder shall be made on the basis of a three hundred sixty (360)-day year of twelve (12) thirty (30)-day months. In the event that any Interest rate provided for herein shall be determined to be unlawful, such Interest rate shall be computed at the highest rate permitted by applicable law. Any payment by the Company of any Interest amount in excess of that permitted by law shall be considered a mistake, with the excess being applied to the Principal of this Note without prepayment premium or penalty.

 

3. Redemption. The Company will have the right to redeem all or any portion of the Note at any time prior to the Maturity Date without premium or penalty of any kind. The redemption price will be payable in cash and is equal to the then outstanding principal amount of this Note plus accrued but unpaid Interest thereon. However, no partial redemption shall excuse or defer the Company’s subsequent payments on or entitle the Company to a release of any collateral used to secure the unredeemed portion of this Note.

 

4. Events of Default. In the event that any of the following (each an “Event of Default”) shall occur:

 

(a) Non-Payment. The Company shall default in the payment of the Principal of, or accrued Interest on, this Note as and when the same shall become due and payable, whether by acceleration or otherwise; or

 

(b) Default in Covenants. The Company shall default in any material manner in the observance or performance of any covenants or agreements set forth in the Purchase Agreement; or

 

(c) Breach of Representations and Warranties. The Company materially breaches any representation or warranty contained in the Purchase Agreement; or

 

(d) Illegality of Note. Any court of competent jurisdiction issues an order declaring the Note or any provision thereunder to be illegal; or

 

(e) Cross Default. There occurs with respect to any Senior Indebtedness: (i) a default with respect to any payment obligation thereunder that then entitles the Holder thereof to declare such indebtedness to be due and payable prior to its stated maturity, or (ii) any other default thereunder that entitles, and has caused, the Holder thereof to declare such indebtedness to be due and payable prior to its stated maturity; or

 

2

 

 

(f) Bankruptcy. The Company shall: (i) admit in writing its inability to pay its debts as they become due; (ii) apply for, consent to, or acquiesce in, the appointment of a trustee, receiver, sequestrator or other custodian for the Company or any of its property, or make a general assignment for the benefit of creditors; (iii) in the absence of such application, consent or acquiesce in, permit or suffer to exist the appointment of a trustee, receiver, sequestrator or other custodian for the Company or for any part of its property; or (iv) permit or suffer to exist the commencement of any bankruptcy, reorganization, debt arrangement or other case or proceeding under any bankruptcy or insolvency law, or any dissolution, winding up or liquidation proceeding, in respect of the Company, and, if such case or proceeding is not commenced by the Company or converted to a voluntary case, such case or proceeding shall be consented to or acquiesced in by the Company or shall result in the entry of an order for relief; then, and so long as such Event of Default is continuing for a period of two (2) business days in the case of non-payment under Section 4(a) or for a period of thirty (30) calendar days in the case of events under Sections 4(b) through 4(d) or for a period of five (5) calendar days in the case of an event under Section 4(e) (and the event which would constitute such Event of Default, if curable, has not been cured), by written notice to the Company from the Holder, all obligations of the Company under this Note shall be immediately due and payable without presentment, demand, protest or any other action nor obligation of the Holder of any kind, all of which are hereby expressly waived, and Holder may exercise any other remedies the Holder may have by contract, at law or in equity. If an Event of Default specified in Section 4(f) above occurs, the Principal of, and accrued Interest on, the Note shall automatically, and without any declaration or other action on the part of any Holder, become immediately due and payable, and Holder may exercise any other remedies the Holder may have by contract, at law or in equity. If the Purchase Agreement is assigned by the Company pursuant to the terms thereof, for purposes of this Section 4, “Company” shall be deemed to include such assignee.

 

5. Covenants. The Company hereby agrees that, so long as the Note remains outstanding and unpaid, or any other amount is owing to the Holder hereunder:

 

(a) The Company will not, without providing at least thirty (30) days prior written notice to the Holder, change its legal name, identity, type of organization, jurisdiction of organization, corporate structure, location of its chief executive office, or its principal place of business or its organizational identification number. The Company will, prior to any change described in the preceding sentence, take all actions requested by the Holder to maintain the perfection and priority of the Holder’s security interest in the Collateral.

 

(b) The Company shall, at its own cost and expense, defend title to the Collateral and the lien and security interest of the Holder therein against the claim of any person claiming against or through the Company and shall maintain and preserve such perfected security interest for so long as this Note shall remain in effect.

 

(c) The Company will not sell, offer to sell, dispose of, convey, assign or otherwise transfer, grant any option with respect to, restrict, or grant, create, permit or suffer to exist any mortgage, pledge, lien, security interest, option, right of first offer, encumbrance or other restriction or limitation of any nature whatsoever on, any of the Collateral or any interest therein except with the prior written consent of the Holder.

 

(d) The Company will keep the Collateral in good order and repair and will not use the same in violation of law or any policy of insurance thereon. The Company will permit the Holder, or its designee, to inspect the Collateral at any reasonable time, wherever located.

 

(e) The Company will pay promptly when due all taxes, assessments, governmental charges, and levies upon the Collateral or incurred in connection with the use or operation of the Collateral or incurred in connection with this Agreement.

 

3

 

 

6. Subordination.

 

(a) All claims of the Holder to Principal, Interest, and any other amounts at any time owed under this Note (collectively, “Junior Indebtedness”) is hereby expressly subordinated in right of payment, as herein set forth, to the prior payment in full of all Senior Indebtedness (as defined below). No payment under Junior Indebtedness shall be made by the Company, nor shall the Holder exercise any remedies under the Junior Indebtedness (including taking any legal action (whether judicial or otherwise) to collect the Junior Indebtedness), if, at the time of such payment, exercise or immediately after giving effect thereto, (i) there shall exist any material “Default” or “Event of Default” under any agreements governing any of the Senior Indebtedness, upon which the Company shall notify the Holder in writing of such Default within five (5) business days of its receipt of notice of the Default from the Senior Lender or (ii) the maturity of any of the Senior Indebtedness has been accelerated and (A) such acceleration has not been waived or (B) such Senior Indebtedness has not been paid in full; provided, however, that (x) in the event that the Holder of any Senior Indebtedness accelerates such Senior Indebtedness, then the Holder may accelerate the indebtedness evidenced by this Note, and (y) if the Company is permitted under the terms of the Senior Indebtedness to pay an amount due and owing under this Note and fails to make such payment, then so long as the terms of the Senior Indebtedness do not prohibit such action, the Holder may exercise its rights to be paid such amount, but only such amount (and Holder shall not be permitted to accelerate hereunder).

 

(b) Upon any payment or distribution of assets of the Company of any kind or character, whether in cash, property or securities, to creditors upon any dissolution or winding up or total or partial liquidation or reorganization of the Company, whether voluntary or involuntary or in bankruptcy, insolvency, receivership or other proceedings, all Senior Indebtedness of the Company shall first be paid in full, or payment thereof provided for in money, before any payment is made under Junior Indebtedness; and upon any such dissolution or winding up or liquidation or reorganization, any distribution of assets of the Company of any kind or character, whether in cash, property or securities, to which the Holder as Holder of the Junior Indebtedness would be entitled except for the provisions hereof, shall be paid by the Company or by any receiver, trustee in bankruptcy, liquidating trustee, agent or other person making such payment or distribution, or by the Holder if received by Holder, directly to the Holder of the Senior Indebtedness, or its representatives, to the extent necessary to pay all such Senior Indebtedness in full, in money, after giving effect to any concurrent prepayment or distribution to or for the benefit of the holders of such Senior Indebtedness, before any payment or distribution is made to the Holder with respect to the Junior Indebtedness.

 

(c) If the holders of the Senior Indebtedness in good faith believe Holder may fail to timely file a proof of claim in any such proceeding, the Holder (s) of the Senior Indebtedness may do so for Holder.

 

(d) In the event that any payment or distribution of assets of the Company of any kind or character, whether in cash, property, or securities, prohibited by the foregoing where the Holder has actual knowledge of a Senior Indebtedness payment default shall be received by the Holder before all the Senior Indebtedness is paid in full, or provisions made for such payment, in accordance with its terms, such payment or distribution shall be held for the benefit of, and shall be paid over or delivered to, the holders of the Senior Indebtedness or their representative or representatives, as their respective interests may appear, for application to the payment of all the Senior Indebtedness remaining unpaid to the extent necessary to pay all such Senior Indebtedness in full, in money, in accordance with its terms, after giving effect to any concurrent payment or distribution to or for the holders of such Senior Indebtedness.

 

(e) The provisions hereof are solely for the purpose of defining the relative rights of the holders of the Senior Indebtedness on the one hand and the Holder as Holder of the Junior Indebtedness on the other hand, and nothing herein shall impair, as between the Company and the Holder, the obligations of the Company under the Junior Indebtedness, which are unconditional and absolute. With this in mind, notwithstanding the other provisions of this Section 6, if and so long as all documents governing the Senior Indebtedness permit one of the actions restricted by this Section 6, the restriction shall be waived, and the restricted action permitted hereunder.

 

4

 

 

(f) No right of any present or future holder of any Senior Indebtedness to enforce the subordination as herein provided shall at any time in any way be prejudiced or impaired by any act or failure to act on the part of the Company or any act or failure to act, in good faith, by any such holder of the Senior Indebtedness, or any noncompliance by the Company with the terms, provisions, and covenants hereof, regardless of any knowledge thereof any holder of the Senior Indebtedness may have or be otherwise charged with. Without in any way limiting the generality of the foregoing, the holders of the Senior Indebtedness may, at any time and from time to time, without the consent of or notice to the Holder, without incurring responsibility to the Holder and without impairing or releasing the subordination provided in this Note or the obligations hereunder of the Holder to the holders of the Senior Indebtedness, do any one or more of the following: (i) change the manner, place or terms of payment or extend the time of payment of, or create, renew or alter, the Senior Indebtedness, or otherwise amend or supplement in any manner the Senior Indebtedness or any instrument evidencing the same or any agreement under which the Senior Indebtedness is outstanding; (ii) sell, exchange, release or otherwise deal with any property pledged, mortgaged or otherwise securing the Senior Indebtedness; (iii) release any person liable or contingently liable in any manner for the payment or collection of the Senior Indebtedness; and/or (iv) exercise or refrain from exercising any rights against the Company or any other person.

 

(g) Each Holder of any Senior Indebtedness, whether such Senior Indebtedness was created or acquired before or after the issuance of this Note, shall be entitled to rely on the subordination provisions set forth in this Note.

 

(h) Notwithstanding the provisions of this Section 6, the Holder shall not be charged with knowledge of the existence of facts which would prohibit the making of any payments on the Junior Indebtedness unless and until the Holder(s) of the Senior Indebtedness or their representatives send written notice to Holder of same.

 

(i) Subject to the payment in full of all the Senior Indebtedness, Holder as Holder of the Junior Indebtedness shall be subrogated to the rights of the holders of the Senior Indebtedness to receive payments or distributions of assets of the Company applicable to the Senior Indebtedness until the Senior Indebtedness shall be paid in full.

 

(j) The Holder shall confirm (in writing) the above subordination provisions if requested by any holder of the Senior Indebtedness and shall execute and deliver such additional subordination agreements, consistent with the foregoing as any holder of Senior Indebtedness may require.

 

(k) For purposes hereof, “Senior Indebtedness” means, with respect to the Company and the Companies, all senior secured indebtedness of the Company and the Companies, whether outstanding on the date of the execution of this Note or thereafter created, to banks, insurance companies, other financial institutions, private equity funds, hedge funds or other similar funds.

 

7. Security Agreement.

 

(a) Grant of Security Interest. To secure the prompt performance and repayment of each and all of the obligations of the Company hereunder to the Holder and its assigns, the Company hereby pledges, grants, assigns, and transfers to the Holder and its assigns a continuing lien on and security interest in and to all of the following property of the Companies, whether now owned or later acquired (collectively the “Collateral” ):

 

(i) All accounts, accounts receivable, contract rights, general intangibles related to or arising from any account, debit balances, Note, documents, chattel paper, instruments, acceptances, drafts or other forms of obligations and receivables of the Companies arising from the sale or lease of inventory or rendition of services by the Companies, or on behalf of the Companies, in the ordinary course of its business or otherwise (all of the foregoing being herein collectively called “Accounts”), whether or not the same are listed on any schedules, assignments or reports furnished to the Holder from time to time, whether such Accounts are now existing or are created at any time hereafter, and all proceeds therefrom including without limitation, proceeds of insurance thereon and all guaranties, securities, and liens which the Companies may hold for the payment of any Accounts, including without limitation, all rights of stoppage in transit, replevin and reclamation and all other rights and remedies of unpaid vendor or lienor, and any liens held by the Companies as a mechanic, contractor, subcontractor, processor, materialman, machinist, manufacturer, artisan, or otherwise.

 

5

 

 

(ii) All documents, instruments, documents of title, policies, and certificates of insurance, guaranties, securities, chattel paper (both tangible and electronic), deposits, proceeds of insurance, cash, liens, or other property relating to Accounts and owned by the Companies or in which the Companies have an interest, which are now or may hereafter be in possession of the Companies or as to which the Companies may now or hereafter control possession by documents of title or otherwise.

 

(iii) All books, records, customer lists, supplier lists, ledgers, evidences of shipping invoices, purchase orders, sales orders, computer records, lists, software, programs, and all other such evidences of the Companies’ business records related to the Accounts, including all cabinets, drawers, etc. that may hold same, all whether now existing or hereafter arising or acquired.

 

(iv) All of the Companies’ tangible property of whatever nature or description, whether real or personal, now or hereafter used, owned, held, or leased, including without limitation all goods, furniture, fixtures, vehicles, equipment, inventory, and supplies.

 

(v) All of the Companies’ payment intangibles, instruments, letters of credit, letter-of-credit rights, money, deposit accounts, investment property, commodity contracts, and commodity accounts.

 

(vi) All of the Companies’ intangible property of whatever nature or description, including without limitation, all intellectual property, general intangibles, software, trade names, trademarks, service marks, computer programs (including source code and object code), patents and copyrights now owned or hereafter acquired.

 

(vii) All renewals, substitutions, replacements, additions, accessions, proceeds, and products of any and all the foregoing.

 

The Company’s grant of such security interests to the Holder shall secure the payment and performance of the indebtedness, obligations, and liabilities of the Company to the Holder of every kind and description, direct and indirect, absolute and contingent, due or to become due, now existing or hereafter arising, that relate to this Note and the rights and remedies created hereunder, and all legal and other professional fees incurred in connection with any of the foregoing. The security interest granted to the Holder hereunder shall be prior to all other interests in the Collateral. Terms used in the preceding collateral description shall have the respective meanings accorded such terms in the Uniform Commercial Code as enacted in the state of Delaware as of the date of this Agreement.

 

(b) The Company hereby agrees that the Holder shall have all the rights and remedies of a secured party under the Uniform Commercial Code as in effect from time to time in the State of Delaware. The Company agrees that at any time, and from time to time, at the request of the Holder, the Company shall execute and deliver (or cause to be executed and delivered) any and all such further instruments and/or documents (including without limitation, UCC-1 financing statements) as the Holder may consider reasonably necessary or desirable in order to effectuate, complete, perfect or preserve and maintain the lien created hereby. Upon any failure by the Company to do so, the Holder may make, execute, record, file, re-record or refile any and all such instruments and documents for and in the name of the Company; the Company hereby irrevocably appoints the Holder as the agent and attorney-in-fact of the Company to do so; and the Company shall reimburse the Holder, on demand, for all costs and expenses incurred by the Holder in connection therewith, such amount being added to the indebtedness arising under the Note.

 

6

 

 

(c) The security interest created hereunder shall terminate upon the irrevocable payment in full by the Company to the Holder of any and all indebtedness, obligations, and liabilities arising from, or in any way related to, the Note.

 

(d) Events of Default; Acceleration of Maturity. If an Event of Default (as defined below) shall have occurred and be continuing (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any governmental authority), then, in addition to the remedies provided for elsewhere in this Note or as a matter of law and without limitation thereof, at the option of the Holder exercised by written notice to the Company, the Holder may (A) foreclose the liens and security interests created under this Note or under any other agreement relating to the Collateral, by any available judicial process, (B) enter any premises where any of the Collateral may be located for the purpose of taking possession or removing the same, and (C) sell, assign, lease or otherwise dispose of the Collateral or any part thereof, either at public or private sale or at any broker’s board, in lots or in bulk, for cash, on credit or otherwise, with or without representations or warranties, and upon such terms as shall be acceptable to the Holder, all at the sole option of the Holder and as the Holder, in its sole discretion, may deem advisable and to the extent permitted by law, the Holder may bid or become a purchaser at any such sale, and the Holder shall have the right, at its option, to apply or be credited with the amount of all or any part of the obligations owing by the Company to the Holder under this Note, against the purchase price bid by the Holder at any such sale. The net cash proceeds resulting from the collection, liquidation, sale, lease, or other disposition of the Collateral (including, without limitation, a sale where the Holder is the purchaser) shall be applied first to the expenses (including reasonable attorneys’ and other professional fees) of retaking, holding, storing, processing and preparing the Collateral for sale, selling, collecting, liquidating and the like, and then to the satisfaction of all such obligations, application as to particular obligations or against Principal or any interest to be in the sole discretion of the Holder. The Holder shall give the Company at least five (5) Business Days prior written notice of the time and place of any public sale of Collateral.

 

(e) Suits for Enforcement. In case any one or more of the Events of Default shall have occurred and be continuing, the Holder may proceed to protect and enforce rights of the Holder either by suit in equity or by action at law, or both, whether for the specific performance of any covenant or Agreement in this Note or in aid of the exercise of any power granted in this Note, including without limitation, possession or foreclosure on the Collateral securing the Note, or the Holder may proceed to enforce the payment of the Note or to enforce any other legal or equitable right of the Holder.

 

(f) Remedies Cumulative. No remedy herein conferred upon the Holder is intended to be exclusive of any other remedy, and each and every such remedy shall be cumulative and shall be in addition to every other remedy given hereunder or now or hereafter existing at law or in equity or by statute or otherwise.

 

(g) Remedies Not Waived. No course of dealing between the Company and the Holder and no delay in exercising any rights hereunder shall operate as a waiver of any rights of the Holder.

8. Mutilated, Destroyed, Lost or Stolen Note. If this Note shall become mutilated or defaced, or be destroyed, lost or stolen, the Company shall execute and deliver a new note of like principal amount in exchange and substitution for the mutilated or defaced Note, or in lieu of and in substitution for the destroyed, lost or stolen Note. In the case of a mutilated or defaced Note, the Holder shall surrender such Note to the Company. In the case of any destroyed, lost, or stolen Note, the Holder shall furnish to the Company: (i) evidence to its satisfaction of the destruction, loss, or theft of such Note and (ii) such security or indemnity (which shall not include the posting of any bond) as may be reasonably required by the Company to hold the Company harmless.

 

7

 

 

9. Waiver of Demand, Presentment, etc. The Company hereby expressly waives demand and presentment for payment, notice of non-payment, protest, notice of protest, notice of dishonor, notice of acceleration or intent to accelerate, bringing of suit and diligence in taking any action to collect amounts called for hereunder, and shall be directly and primarily liable for the payment of all sums owing and to be owing hereunder, regardless of and without any notice, diligence, act or omission as or with respect to the collection of any amount called for hereunder. The Company agrees that, in the event of an Event of Default, to reimburse the Holder for all reasonable costs and expenses (including reasonable legal fees of one counsel) incurred in connection with the enforcement and collection of this Note.

 

10. Payment. All payments with respect to this Note shall be made in lawful money of the United States of America at the address of the Holder as of the date hereof or as designated in writing by the Holder from time to time. The receipt by the Holder of immediately available funds shall constitute a payment of Principal and Interest hereunder and shall satisfy and discharge the liability for Principal and Interest on this Note to the extent of the sum represented by such payment.

 

11. Assignment. The rights and obligations of the Company and the Holder of this Note shall be binding upon and inure to the benefit of the successors and permitted assigns of the parties hereto. To complete an assignment or transfer this Note, the Holder shall deliver a completed and executed Form of Assignment attached hereto as Exhibit “C” and surrender and deliver this Note, duly endorsed, to the Company’s office or such other address which the Company shall designate, upon receipt of which a new Note, in substantially the form of this Note (any such new Note, a “New Note”), evidencing the portion of this Note so transferred shall be issued to the transferee and a New Note evidencing the remaining portion of this Note not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New Note by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations in respect of the New Note that the Holder has in respect of this Note. Interest and Principal are payable only to the registered Holder of this Note set forth on the books and records of the Company.

 

12. Amendment; Waiver; Modification. Any provision of this Note, including, without limitation, the due date hereof and the observance of any term hereof, may be amended, waived, or modified (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Holder.

 

13. Notices. Any notice, request, or other communication required or permitted hereunder shall be in writing and shall be deemed to have been duly given if given in accordance with the provisions of the Purchase Agreement.

 

14. Governing Law and Arbitration. This Note shall be governed in all respects, including validity, interpretation, and effect, by the internal laws of the State of Florida. Any dispute shall be resolved by arbitration conducted pursuant to Section 10.7 of the Purchase Agreement. The provisions of this Section 14 shall survive the entry of any judgment and will not merge, or be deemed to have merged, into any judgment.

 

15. Headings. The descriptive headings contained in this Note are included for convenience of reference only and will not affect in any way the meaning or interpretation of this Note.

 

16. Severability. If one or more provisions of this Note are held to be unenforceable under applicable law, such provisions shall be excluded from this Note, and the balance of this Note shall be interpreted as if such provisions were so excluded and shall be enforceable in accordance with its terms.

 

[Signature Page Follows]

 

8

 

 

IN WITNESS WHEREOF, the Company has duly executed and delivered this Note as of the date first above written.

 

  Smart for Life, Inc.
     
  By: /s/ Alfonso J. Cervantes
  Name:  Alfonso J. Cervantes
  Title: Executive Chairman

 

 

 

 

EXHIBIT “A”

 

AMORTIZATION SCHEDULE

 

Payment Date  Payment   Principal Paid   Interest Paid   Remaining Balance 
Nov-22   -    -    -   $3,275,854.70 
Feb-23  $63,331.45   $46,952.18   $16,379.27   $3,228,902.52 
Mar-23  $63,331.45   $47,186.94   $16,144.51   $3,181,715.59 
Apr-23  $63,331.45   $47,422.87   $15,908.58   $3,134,292.72 
May-23  $63,331.45   $47,659.99   $15,671.46   $3,086,632.73 
Jun-23  $63,331.45   $47,898.29   $15,433.16   $3,038,734.45 
Jul-23  $63,331.45   $48,137.78   $15,193.67   $2,990,596.67 
Aug-23  $63,331.45   $48,378.47   $14,952.98   $2,942,218.21 
Sep-23  $63,331.45   $48,620.36   $14,711.09   $2,893,597.85 
Oct-23  $63,331.45   $48,863.46   $14,467.99   $2,844,734.39 
Nov-23  $63,331.45   $49,107.78   $14,223.67   $2,795,626.61 
Dec-23  $63,331.45   $49,353.32   $13,978.13   $2,746,273.30 
Jan-24  $63,331.45   $49,600.08   $13,731.37   $2,696,673.21 
Feb-24  $63,331.45   $49,848.08   $13,483.37   $2,646,825.13 
Mar-24  $63,331.45   $50,097.32   $13,234.13   $2,596,727.81 
Apr-24  $63,331.45   $50,347.81   $12,983.64   $2,546,380.00 
May-24  $63,331.45   $50,599.55   $12,731.90   $2,495,780.45 
Jun-24  $63,331.45   $50,852.55   $12,478.90   $2,444,927.90 
Jul-24  $63,331.45   $51,106.81   $12,224.64   $2,393,821.09 
Aug-24  $2,405,790.20   $2,381,851.99   $11,969.11   $0.00 

 

 

 

 

EXHIBIT “C”

 

FORM OF ASSIGNMENT

 

TO:Smart for Life, Inc.

 

 

FOR VALUE RECEIVED, the undersigned hereby sells, assigns, and transfers unto ___________________ (name), __________________________________________ (address), US$____________ of six percent (6%) Secured Subordinated Promissory Note (“Note”) of Smart for Life, Inc. (the “Company”), including any and all accrued and unpaid Interest owing thereon, registered in the name of the undersigned on the records of the Company represented by the within certificate, and irrevocably appoints ___________________ the attorney of the undersigned to transfer the said securities on the books or register with full power of substitution.

 

DATED this ________ day of, __________________, 2022.

 

   
(Signature of Registered Note Holder)  
   
   
(Print name of Registered Note Holder)  

 

Instructions:

 

1.Signature of Holder must be the signature of the person appearing on the face of the Note.

 

2.If the transfer of Note is signed by a trustee, executor, administrator, curator, guardian, attorney, officer of a corporation, or any person acting in a fiduciary or representative capacity, the certificate must be accompanied by evidence of authority to sign satisfactory to the Company.